Can We Smell A Trillion Odors?

A reanalysis calls into question a year-old claim that humans can decipher at least 1 trillion different scents.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

PIXABAY, PUBLICDOMAINPICTURESIn 2014, Rockefeller University’s Leslie Vosshall and colleagues reported the results of an olfaction study in humans, concluding that people are able to discriminate at least one trillion different odors. That number smashed the old approximation by many orders of magnitude, and far surpassed the estimates for how many colors and tones humans can distinguish. Now, citing potential flaws in that analysis, an independent team is challenging the published figure.

“The first main concern is that the estimated number of discriminable stimuli depends steeply, systematically, and non-asymptotically on choices of arbitrary experimental parameters, among them the number of subjects enrolled, the number of discrimination tests performed, and the threshold for statistical significance,” Arizona State University’s Richard Gerkin and Bates College’s Jason Castro wrote in their study, published in eLife this week (July 7).

Gerkin and Castro picked through the Vosshall team’s methodology, finding that different statistical or experimental conditions would have yielded estimates of the number of detectable odor stimuli anywhere from 5,000 to 1029.

“We also point out that the conclusion in the 2014 paper relies heavily on untested assumptions about smell perception. And the equation used actually shows that the number of distinguishable ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies